A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 Trial. [electronic resource]
Producer: 20111227Description: 838-46 p. digitalISSN:- 1522-9645
- Adolescent
- Adult
- Aged
- Aspirin -- therapeutic use
- Clopidogrel
- Coronary Artery Disease -- complications
- Cross-Over Studies
- Diabetes Mellitus, Type 2 -- complications
- Diabetic Angiopathies -- drug therapy
- Double-Blind Method
- Female
- Humans
- Male
- Middle Aged
- Piperazines -- administration & dosage
- Platelet Activation -- drug effects
- Platelet Aggregation Inhibitors -- administration & dosage
- Prasugrel Hydrochloride
- Prospective Studies
- Thiophenes -- administration & dosage
- Ticlopidine -- administration & dosage
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.